3.10.BPS1 Best practice statement
Assessment of auditory and vestibular function should form part of the standard…
Assessment of auditory and vestibular function should form part of the standard Friedreich ataxia management protocol. Each individual should be evaluated on an annual basis or more regularly if the individual notices a change in auditory performance or balance.
Part of 3.10 Auditory and vestibular function in Friedreich ataxia
References (20)
1. Harding AE. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain. 1981;104(3):589-620.
2. Dürr A, Cossee M, Agid Y, Campuzano V, Mignard C, Penet C, et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med. 1996;335(16):1169-75.
3. Rance G, Fava R, Baldock H, Chong A, Barker E, Corben L, et al. Speech perception ability in individuals with Friedreich ataxia. Brain. 2008;131:2002-12.
4. Satya-Murti S, Cacace A, Hanson P. Auditory dysfunction in Friedreich ataxia: result of spiral ganglion degeneration. Neurology. 1980;30(10):1047-53.
5. Jabbari B, Schwartz DM, MacNeil DM, Coker SB. Early abnormalities of brainstem auditory evoked potentials in Friedreich's ataxia: evidence of primary brainstem dysfunction. Neurology. 1983;33(8):1071-4.
6. Starr A, Picton TW, Sininger Y, Hood LJ, Berlin CI. Auditory neuropathy. Brain. 1996;119 ( Pt 3):741-53.
7. Lopez-Diaz-de-Leon E, Silva-Rojas A, Ysunza A, Amavisca R, Rivera R. Auditory neuropathy in Friedreich ataxia. A report of two cases. Int J Pediatr Otorhinolaryngol. 2003;67(6):641-8.
8. Spoendlin H. Optic cochleovestibular degenerations in hereditary ataxias. II. Temporal bone pathology in two cases of Friedreich's ataxia with vestibulo-cochlear disorders. Brain. 1974;97(1):41-8.
9. Ell J, Prasher D, Rudge P. Neuro-otological abnormalities in Friedreich's ataxia. J Neurol Neurosurg Psychiatry. 1984;47(1):26-32.
10. Fahey MC, Cremer PD, Swee TA, Millist L, Todd MJ, White OB, et al. Vestibular, saccadic and fixation abnormalities in genetically confirmed Friedreich ataxia. Brain. 2008;131:1035-45.
11. Maudoux A, Teissier N, Francois M, Van Den Abbeele T, Alberti C, Husson I, et al. Vestibular impact of Friedreich ataxia in early onset patients. Cerebellum Ataxias. 2020;7:6.
12. Monday L, Lesperance J, Lemieux B, Saint-Vincent H. Follow-up study of electronystagmographic findings in Friedreich's ataxia patients and evaluation of their relatives. Can J Neurol Sci. 1984;11(4 Suppl):570-3.
13. Monday LA, Lemieux B, St Vincent H, Barbeau A. Clinical and electronystagmographic findings in Friedreich's ataxia. Can J Neurol Sci. 1978;5(1):71-3.
14. Oppenheimer DR. Brain lesions in Friedreich's ataxia. Can J Neurol Sci. 1979;6(2):173-6.
15. Rance G, Corben L, Barker E, Carew P, Chisari D, Rogers M, et al. Auditory perception in individuals with Friedreich's ataxia. Audiology Neurootol. 2010;15(4):229-40.
16. Rance G, Corben LA, Du Bourg E, King A, Delatycki MB. Successful treatment of auditory perceptual disorder in individuals with Friedreich ataxia. Neuroscience. 2010;171(2):552-5.
17. Tye-Murray N. Foundations of aural rehabilitation: children, adults, and their family members. 3rd ed. New York: Delmar; 2009.
18. Miyamoto RT, Kirk KI, Renshaw J, Hussain D. Cochlear implantation in auditory neuropathy. Laryngoscope. 1999;109(2 Pt 1):181-5.
19. Frewin B, Chung M, Donnelly N. Bilateral cochlear implantation in Friedreich's ataxia: a case study. Cochlear Implants Int. 2013;14(5):287-90.
20. Rance G, Starr A. Pathophysiological mechanisms and functional hearing consequences of auditory neuropathy. Brain. 2015;138(Pt 11):3141-58.
Disclaimer, intended use and funding
Disclaimer
The Clinical Management Guidelines for Friedreich ataxia (‘Guidelines’) are protected by copyright owned by the authors who contributed to their development or said authors’ assignees.
These Guidelines are systematically developed evidence statements incorporating data from a comprehensive literature review of the most recent studies available (up to the Guidelines submission date) and reviewed according to the Grading of Recommendations, Assessment Development and Evaluations (GRADE) framework © The Grade Working Group.
Guidelines users must seek out the most recent information that might supersede the diagnostic and treatment recommendations contained within these Guidelines and consider local variations in clinical settings, funding and resources that may impact on the implementation of the recommendations set out in these Guidelines.
The authors of these Guidelines disclaim all liability for the accuracy or completeness of the Guidelines, and disclaim all warranties, express or implied to their incorrect use.
Intended Use
These Guidelines are made available as general information only and do not constitute medical advice. These Guidelines are intended to assist qualified healthcare professionals make informed treatment decisions about the care of individuals with Friedreich ataxia. They are not intended as a sole source of guidance in managing issues related to Friedreich ataxia. Rather, they are designed to assist clinicians by providing an evidence-based framework for decision-making.
These Guidelines are not intended to replace clinical judgment and other approaches to diagnosing and managing problems associated with Friedreich ataxia which may be appropriate in specific circumstances. Ultimately, healthcare professionals must make their own treatment decisions on a case-by-case basis, after consultation with their patients, using their clinical judgment, knowledge and expertise.
Guidelines users must not edit or modify the Guidelines in any way – including removing any branding, acknowledgement, authorship or copyright notice.
Funding
The authors of this document gratefully acknowledge the support of the Friedreich Ataxia Research Alliance (FARA). The views and opinions expressed in the Guidelines are solely those of the authors and do not necessarily reflect the official policy or position of FARA.